drugset
drugset / Trial / NCT05360576

An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study

NCT05360576 ↗

Phase 2 Completed 40 enrolled Lupin Research Inc
RandomizedCrossoverOpen-labelPrevention

Summary

An Open-label, Randomized, 2-Period, Crossover Study to Assess the Comparative Pharmacokinetics of LSP-5415 and NuvaRing® in Healthy Adult Females

Timeline

Start
2022-02-24
Primary completion
2022-07-04
Completion
2022-07-04

Drugs

EvaluationDrugModalityDoseRoute
Subject LSP-5415 Unknown — —
Subject NuvaRing Other / unclassified — —

Indications

No indication recorded.